# Nuclide record nuclidium (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/nuclidium/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "nuclidium" ;
  schema:name "Nuclidium"@en ;
  schema:alternateName "Nuclidium AG"@en ;
  schema:description "A Swiss biotech using two forms of radioactive copper, one for scanning and one for treatment, joined to the same targeting molecule so the same drug design can both find and then destroy a tumour."@en ;
  schema:url <https://nuclide.cc/companies/nuclidium/>, <https://nuclidium.com> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://nuclidium.com/>, <https://nuclidium.com/pipeline/>, <https://nuclidium.com/nuclidium-announces-issuance-of-new-u-s-patent-covering-its-61cu-based-radiodiagnostic-program-for-psma-positive-prostate-cancer/> ;
  nuclide:status "active" ;
  nuclide:tag "copper-61", "copper-67", "theranostics", "PSMA" ;
  schema:addressCountry "CH" ;
  nuclide:related <https://nuclide.cc/targets/psma/>, <https://nuclide.cc/indications/prostate-mcrpc/>, <https://nuclide.cc/companies/clarity-pharmaceuticals/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/cu-64/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/cu-67/> .